Evidence map›Paper›PMID 34250212›Full record

ArticleBio-protocol2021

Nami Kitajima, Kenji Takikawa, Hiroshi Sekiya, Daisuke Asanuma, Hirokazu Sakamoto, Shigeyuki Namiki, Masamitsu Iino, Kenzo Hirose

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bio-protocol, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nami KitajimaDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kenji TakikawaDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroshi SekiyaDepartment of Physiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Daisuke AsanumaDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hirokazu SakamotoDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shigeyuki NamikiDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masamitsu IinoDepartment of Cellular and Molecular Pharmacology, Nihon University School of Medicine, Tokyo, Japan.
Kenzo HiroseDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine 5'-triphosphate (ATP) works as an extracellular signaling molecule for cells in the brain, such as neurons and glia. Cellular communication via release of ATP is involved in a range of processes required for normal brain functions, and aberrant communication is associated with brain disorders. To investigate the mechanisms underlying these cellular processes, various techniques have been developed for the measurement of extracellular ATP. To monitor the dynamics of extracellular ATP signaling with high spatiotemporal resolution, we recently developed a hybrid-type ATP optical sensor (ATPOS) that enables

Indexed as

ATPBrainExtracellular signaling moleculeFluorescent sensorIn vivo imaging

Identifiers

PMID34250212
PMCPMC8250345
OpenAlexW3167466462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.